newsfilter
← Latest News
Business Wire·

Athersys Director Jane Wasman Appointed Board Chair

Athersys, Inc. (NASDAQ:ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces changes to its Board of Directors following the Company's recent 2023